HCP
AMN icon

Hexagon Capital Partners’s AMN Healthcare AMN Stock Holding History

Hexagon Capital Partners’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250
Closed -$6.12K – 160
2025
Q1 		$6.12K Buy
250
+12
+5% +$308 ﹤0.01% 1113
2024
Q4 		$5.69K Sell
238
-215
-47% -$6.83K ﹤0.01% 1172
2024
Q3 		$19.2K Sell
453
-44
-9% -$2.31K ﹤0.01% 725
2024
Q2 		$25.5K Buy
497
+86
+21% +$4.87K 0.01% 608
2024
Q1 		$25.7K Buy
411
+51
+14% +$3.47K 0.01% 604
2023
Q4 		$27K Buy
360
+147
+69% +$10.5K 0.01% 557
2023
Q3 		$18.1K Buy
213
+118
+124% +$11.2K ﹤0.01% 582
2023
Q2 		$10.4K Buy
95
+38
+67% +$3.6K ﹤0.01% 737
2023
Q1 		$4.73K Buy
57
+32
+128% +$3.01K ﹤0.01% 896
2022
Q4 		$2.57K Sell
25
-19
-43% -$2.19K ﹤0.01% 1043
2022
Q3 		$5K Sell
44
-21
-32% -$2.3K ﹤0.01% 916
2022
Q2 		$7K Buy
65
+61
+1,525% +$6.04K ﹤0.01% 712
2022
Q1 		$0 Buy
+4
New +$415 ﹤0.01% 914

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hexagon Capital Partners's AMN Position: Q2 2025 in Review

Hexagon Capital Partners sold out of AMN Healthcare (AMN) in Q2 2025, closing a stake of 250 shares — an estimated $6.12K sold.

Hexagon Capital Partners first reported a position in AMN in Q1 2022 and held it in 13 quarters. The position peaked at $27K in Q4 2023. 248 funds tracked by Wall St. Rank hold AMN as of Q2 2025.

  • Hexagon Capital Partners reported no remaining AMN Healthcare position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 250 AMN Healthcare shares in Q2 2025, an estimated $6.12K.
  • Hexagon Capital Partners first reported a position in AMN Healthcare in Q1 2022 and held it in 13 quarters.
  • Hexagon Capital Partners's AMN Healthcare position peaked at $27K in Q4 2023.
  • 248 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.